RIVASTIGMINE Side Effects

6979727-3 | Crying, Excoriation, Fall, Middle Insomnia, Moaning, Rapid Eye Movements Sleep Abnormal
on Jul 26, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 88 years of age, was diagnosed with dementia (What is dementia?) and was treated with Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: crying, excoriation, fall (What is fall?), middle insomnia, moaning, rapid eye movements sleep abnormal. Rivastigmine dosage: 1.5 Mg To 3 Mg.

6977329-6 | Depressed Level Of Consciousness
Patient was taking Rivastigmine (View Usage). Patient had the following side effects: depressed level of consciousness on Aug 27, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 105.8 lb, was diagnosed with dementia (What is dementia?), pain (What is pain?) and. Rivastigmine dosage: 4.6 Mg. During the same period patient was treated with FENTANYL CITRATE (50ug) (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

6937722-4 | Application Site Erythema, Application Site Pruritus, Dizziness, Rash
Adverse event was reported on Aug 20, 2010 by a Male patient taking Rivastigmine (View Usage) (Dosage: 9.5 Mg Every Day Po) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 82 years of age, weighting 160.5 lb, After Rivastigmine was administered, patient had the following side effects: application site erythema, application site pruritus, dizziness (What is dizziness?), rash (What is rash?).

6914911-6 | Crying, Excoriation, Fall, Middle Insomnia, Moaning, Rapid Eye Movements Sleep Abnormal
on Jul 26, 2010 Male patient from UNITED KINGDOM , 88 years of age, was diagnosed with dementia (What is dementia?) and was treated with Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: crying, excoriation, fall (What is fall?), middle insomnia, moaning, rapid eye movements sleep abnormal. Rivastigmine dosage: 1.5 Mg To 3 Mg.


6816333-5 | Apathy, Confusional State, Illusion, Paranoia, Poverty Of Speech, Somnolence
on Jun 21, 2010 Female patient from UNITED STATES , 82 years of age, was treated with Rivastigmine (View Usage). Patient had the following side effects: apathy, confusional state, illusion, paranoia, poverty of speech, somnolence. Rivastigmine dosage: . During the same period patient was treated with LAMOTRIGINE (50 Mg) (View Lamotrigine Review and Lamotrigine Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ).

6816293-7 | Abnormal Behaviour, Aggression, Agitation, Anger, Cognitive Disorder, Insomnia, Mood Altered, Verbal Abuse
Patient was taking Rivastigmine (View Usage). After Rivastigmine was administered, patient had the following side effects: abnormal behaviour, aggression, agitation, anger, cognitive disorder, insomnia, mood altered, verbal abuse on Jun 21, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with dementia alzheimer's type, depression (What is depression?) and. Rivastigmine dosage: Unk,unk. During the same period patient was treated with MEMANTINE (Unk,unk) (View Memantine Review and Memantine Label ), ANTIDEPRESSANTS (Unk,unk) (View Antidepressants Review and Antidepressants Label ).

6781280-4 | Cellulitis, Confusional State, Dementia, Rash
Adverse event was reported on Jun 09, 2010 by a Female patient taking Rivastigmine (View Usage) (Dosage: 4.6 Mg) . Location: UNITED KINGDOM , 87 years of age, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), confusional state, dementia (What is dementia?), rash (What is rash?). During the same period patient was treated with ADCAL (View Adcal Review and Adcal Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6760535-3 | Abnormal Behaviour, Bradykinesia, Cognitive Disorder, Excoriation, Fall, Moaning, Parasomnia, Rapid Eye Movements Sleep Abnormal, Screaming
on May 25, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 88 years of age, was diagnosed with dementia alzheimer's type, rapid eye movements sleep abnormal and was treated with Rivastigmine (View Usage). Patient had the following side effects: abnormal behaviour, bradykinesia, cognitive disorder, excoriation, fall (What is fall?), moaning, parasomnia, rapid eye movements sleep abnormal, screaming. Rivastigmine dosage: 1.5 Mg, Bid. During the same period patient was treated with CLONAZEPAM (0.5 Mg, Qd) (View Clonazepam Review and Clonazepam Label ).

6449663-X | Abdominal Distension, Asthenia, Fatigue, Hepatitis Cholestatic, Mixed Liver Injury, Ocular Icterus, Rash, Urine Colour Abnormal
on Nov 12, 2009 Female patient from ITALY , 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Rivastigmine (View Usage). After Rivastigmine was administered, patient had the following side effects: abdominal distension, asthenia, fatigue, hepatitis cholestatic, mixed liver injury, ocular icterus, rash (What is rash?), urine colour abnormal. Rivastigmine dosage: 4.6 Mg 24 Hourly. During the same period patient was treated with RAMIPRIL (2.5mg Daily) (View Ramipril Review and Ramipril Label ), ASPIRIN (100mg Daily) (View Aspirin Review and Aspirin Label ), VALPROIC ACID (150mg Daily) (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

5963769-0 | Blood Pressure Diastolic Decreased, Bradycardia, Confusional State, Depressed Level Of Consciousness, Disorientation, Faecal Incontinence, Fall, Loss Of Consciousness, Malaise
Patient was taking Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic decreased, bradycardia, confusional state, depressed level of consciousness, disorientation, faecal incontinence, fall (What is fall?), loss of consciousness, malaise on Nov 21, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 127.0 lb, was diagnosed with dementia (What is dementia?) and. Rivastigmine dosage: Transdermal. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ). Patient was hospitalized.

5862767-5 | Dystonia
Adverse event was reported on Jul 17, 2008 by a Female patient taking Rivastigmine (View Usage) (Dosage: ) . Location: UNITED STATES , 61 years of age, Patient had the following side effects: dystonia (What is dystonia?). During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DEXAMPHETAMINE (View Dexamphetamine Review and Dexamphetamine Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), TRANYLCYPROMINE SULFATE (View Tranylcypromine Sulfate Review and Tranylcypromine Sulfate Label ). Patient was hospitalized.

5657672-3 | Abnormal Behaviour, Blood Creatine Phosphokinase Increased, Blood Pressure Decreased, Body Temperature Increased, Gait Disturbance, Hyperhidrosis, Mental Impairment, Muscle Rigidity
on Feb 28, 2008 Male patient from UNITED STATES , 58 years of age, was treated with Rivastigmine (View Usage). After Rivastigmine was administered, patient had the following side effects: abnormal behaviour, blood creatine phosphokinase increased, blood pressure decreased, body temperature increased, gait disturbance, hyperhidrosis, mental impairment, muscle rigidity. Rivastigmine dosage: 3 Mg, Bid. During the same period patient was treated with OLANZAPINE (2.5 Mg/day) (View Olanzapine Review and Olanzapine Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ). Patient was hospitalized.

5635934-3 | Circulatory Collapse
on Feb 21, 2008 Male patient from UNITED KINGDOM , 67 years of age, weighting 132.3 lb, was diagnosed with dementia (What is dementia?), parkinson's disease (What is parkinson's disease?), depression (What is depression?) and was treated with Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse. Rivastigmine dosage: 3 Mg, Unk. During the same period patient was treated with ENTACAPONE (1 Df, Bid) (View Entacapone Review and Entacapone Label ), MADOPAR (1 Df, Qd) (View Madopar Review and Madopar Label ), MIRTAZAPINE (30 Mg, Qd) (View Mirtazapine Review and Mirtazapine Label ).

5591088-3 | Anxiety, Chest Discomfort, Dyspnoea, Dystonia
Patient was taking Rivastigmine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chest discomfort, dyspnoea, dystonia (What is dystonia?) on Jan 07, 2008 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with dementia alzheimer's type, anxiety (What is anxiety?), depressive symptom, bipolar ii disorder, reflux oesophagitis, hypothyroidism, insomnia and. Rivastigmine dosage: 3 Mg, Bid. During the same period patient was treated with CLONAZEPAM (NGX) (1.5 Mg, Tid) (View Clonazepam (ngx) Review and Clonazepam (ngx) Label ), DEXTROAMPHETAMINE (15 Mg, Bid) (View Dextroamphetamine Review and Dextroamphetamine Label ), LAMOTRIGINE (100 Mg, Bid) (View Lamotrigine Review and Lamotrigine Label ), LANSOPRAZOLE (30 Mg, Qd) (View Lansoprazole Review and Lansoprazole Label ), LEVOTHYROXINE SODIUM (125 Mg, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MEMANTINE HCL (10 Mg, Bid) (View Memantine Hcl Review and Memantine Hcl Label ), QUETIAPINE (300 Mg, Qhs) (View Quetiapine Review and Quetiapine Label ), RISPERIDONE (3 Mg/d) (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

5536932-0 | Confusional State, Dizziness, Fall, Syncope
Adverse event was reported on Dec 04, 2007 by a Male patient taking Rivastigmine (View Usage) (Dosage: 4 Mg, Bid) was diagnosed with dementia alzheimer's type, insomnia, thrombosis prophylaxis, blood cholesterol increased, diabetes mellitus, hypertension and. Location: UNITED KINGDOM , 83 years of age, After Rivastigmine was administered, patient had the following side effects: confusional state, dizziness (What is dizziness?), fall (What is fall?), syncope. During the same period patient was treated with ZOPICLONE (3.75 Mg, Qd) (View Zopiclone Review and Zopiclone Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), ATORVASTATIN (10 Mg, Bid) (View Atorvastatin Review and Atorvastatin Label ), GLICLAZIDE (5 Mg, Bid) (View Gliclazide Review and Gliclazide Label ), RAMIPRIL (5 Mg, Bid) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5441336-5 | Dystonia, Gait Deviation
on Aug 27, 2007 Male patient from FRANCE , 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?), gait deviation. Rivastigmine dosage: .

5401106-0 | Blood Pressure Increased, Fall, Immobile, Pyrexia
on Jul 23, 2007 Male patient from UNITED KINGDOM , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), depression (What is depression?) and was treated with Rivastigmine (View Usage). Patient had the following side effects: blood pressure increased, fall (What is fall?), immobile, pyrexia. Rivastigmine dosage: 1.5 Mg, Bid. During the same period patient was treated with CO CARELDOPA (25/100 Tabs (8 Daily)) (View Co-careldopa Review and Co-careldopa Label ), SINEMET CR (2 Df, Qd) (View Sinemet Cr Review and Sinemet Cr Label ), LOFEPRAMINE (70 Mg, Tid) (View Lofepramine Review and Lofepramine Label ).

5323417-X | Abnormal Behaviour, Accidental Exposure, Balance Disorder, Gait Disturbance, Meniere's Disease, Overdose, Vertigo
Patient was taking Rivastigmine (View Usage). After Rivastigmine was administered, patient had the following side effects: abnormal behaviour, accidental exposure, balance disorder, gait disturbance, meniere's disease (What is meniere's disease?), overdose, vertigo on May 03, 2007 from NETHERLANDS Additional patient health information: Female patient , 71 years of age, weighting 165.3 lb, was diagnosed with dementia alzheimer's type, pain (What is pain?) and. Rivastigmine dosage: Twice Daily. During the same period patient was treated with REMINYL (8 Mg, Qd) (View Reminyl Review and Reminyl Label ), ACETYLSALICYLIC ACID SRT (80 Mg, Qd) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), IRON SUPPLEMENTS (1df Per Time) (View Iron Supplements Review and Iron Supplements Label ).

5317415-X | Abnormal Behaviour, Accidental Exposure, Balance Disorder, Gait Disturbance, Meniere's Disease, Vertigo
Adverse event was reported on Apr 23, 2007 by a Female patient taking Rivastigmine (View Usage) (Dosage: Twice Daily) was diagnosed with dementia alzheimer's type, pain (What is pain?) and. Location: NETHERLANDS , 71 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, accidental exposure, balance disorder, gait disturbance, meniere's disease (What is meniere's disease?), vertigo. During the same period patient was treated with REMINYL (8 Mg, Qd) (View Reminyl Review and Reminyl Label ), ACETYLSALICYLIC ACID SRT (80 Mg, Qd) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), IRON SUPPLEMENTS (1df Per Time) (View Iron Supplements Review and Iron Supplements Label ).

5245355-3 | Decreased Appetite, Fall, Mobility Decreased, Syncope
on Feb 19, 2007 Female patient from UNITED KINGDOM , 83 years of age, weighting 98.00 lb, was diagnosed with dementia (What is dementia?) and was treated with Rivastigmine (View Usage). Patient had the following side effects: decreased appetite, fall (What is fall?), mobility decreased, syncope. Rivastigmine dosage: Unk, Unk. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5113644-9 | Cardiac Arrest, Electromechanical Dissociation
on Sep 21, 2006 Male patient from UNITED KINGDOM , 68 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), depression (What is depression?) and was treated with Rivastigmine (View Usage). After Rivastigmine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), electromechanical dissociation. Rivastigmine dosage: 1.5mg Daily. During the same period patient was treated with AMLODIPINE (5mg Daily) (View Amlodipine Review and Amlodipine Label ), CABERGOLINE (2 Mg, Bid) (View Cabergoline Review and Cabergoline Label ), FINASTERIDE (5mg Daily) (View Finasteride Review and Finasteride Label ), MADOPAR (1 Df, 6qd) (View Madopar Review and Madopar Label ), QUETIAPINE (25 Mg, Bid) (View Quetiapine Review and Quetiapine Label ), TRIHEXYPHENIDYL HCL (2 Mg, Tid) (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ).

5017888-6 | Accidental Exposure, Cholinergic Syndrome, Crying, Hyporeflexia, Hypotonia, Miosis, Muscular Weakness
Patient was taking Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, cholinergic syndrome, crying, hyporeflexia, hypotonia, miosis, muscular weakness on Jul 20, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 16.53 lb, . Rivastigmine dosage: . Patient was hospitalized.

4910719-1 | Erythema Multiforme, Rash
Adverse event was reported on Feb 06, 2006 by a Male patient taking Rivastigmine (View Usage) (Dosage: 1.5 Mg, Qd) was diagnosed with confusional state and. Location: UNITED KINGDOM , 71 years of age, weighting 167.6 lb, Patient had the following side effects: erythema multiforme, rash (What is rash?). During the same period patient was treated with MADOPAR (125 Mg, Qid) (View Madopar Review and Madopar Label ).

4851011-3 | Angioneurotic Oedema, Urticaria
on Dec 05, 2005 Male patient from UNITED KINGDOM , 74 years of age, weighting 165.3 lb, was diagnosed with dementia (What is dementia?), parkinsonism, osteoarthritis (What is osteoarthritis?) and was treated with Rivastigmine (View Usage). After Rivastigmine was administered, patient had the following side effects: angioneurotic oedema, urticaria. Rivastigmine dosage: 15 Mg Bid (one Dose Only). During the same period patient was treated with SINEMET (275 Mg, Tid) (View Sinemet Review and Sinemet Label ), ENTACAPONE (200 Mg, Tid) (View Entacapone Review and Entacapone Label ), NAPROXEN (250 Mg, Tid) (View Naproxen Review and Naproxen Label ), LORAZEPAM (0.5 Mg, Prn) (View Lorazepam Review and Lorazepam Label ).

4723338-7 | Cholinergic Syndrome, Crying, Hyporeflexia, Hypotonia, Miosis, Muscular Weakness
on Jul 20, 2005 Female patient from UNITED STATES , weighting 15.43 lb, was treated with Rivastigmine (View Usage). Patient experienced the following unwanted or unexpected effects: cholinergic syndrome, crying, hyporeflexia, hypotonia, miosis, muscular weakness. Rivastigmine dosage: . Patient was hospitalized.

4669532-5 | Cogwheel Rigidity, Parkinsonism, Tremor
Patient was taking Rivastigmine (View Usage). Patient had the following side effects: cogwheel rigidity, parkinsonism, tremor on May 18, 2005 from Additional patient health information: Female patient , 83 years of age, . Rivastigmine dosage: . During the same period patient was treated with NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

4615397-7 | Dystonia, Pleurothotonus
Adverse event was reported on Mar 16, 2005 by a Female patient taking Rivastigmine (View Usage) (Dosage: 3 Mg/d) was diagnosed with dementia alzheimer's type and. Location: , 84 years of age, After Rivastigmine was administered, patient had the following side effects: dystonia (What is dystonia?), pleurothotonus. During the same period patient was treated with BROMAZEPAM (1.5 Mg/d) (View Bromazepam Review and Bromazepam Label ).